Teradyne, Inc. (NASDAQ:TER) Receives Average Rating of “Hold” from Brokerages
Teradyne, Inc. (NASDAQ:TER – Get Free Report) has received an average recommendation of “Hold” from the fifteen research firms that are presently covering the company,...
JPMorgan Chase & Co. Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $64.00
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price cut by JPMorgan Chase & Co. from $72.00 to $64.00 in a research report released...
Needham & Company LLC Begins Coverage on Artiva Biotherapeutics (NASDAQ:ARTV)
Needham & Company LLC began coverage on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a research note published on Tuesday morning, MarketBeat.com reports....
Canaccord Genuity Group Reaffirms Buy Rating for Atara Biotherapeutics (NASDAQ:ATRA)
Canaccord Genuity Group reaffirmed their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research report report published on Tuesday morning,...
Ascendis Pharma A/S (NASDAQ:ASND) Price Target Increased to $196.00 by Analysts at Jefferies Financial Group
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) had its price target increased by Jefferies Financial Group from $174.00 to $196.00 in a research note published...
Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a report released on Wednesday. The brokerage set a...